Information:
Error:
ID
18869
Description
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).
Keywords
Versions (2)
- 11/15/16 11/15/16 -
- 11/23/16 11/23/16 -
Uploaded on
November 23, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC-ND 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
WTZ-GIST-09-01 (Imatinib + LBH589) Informed Consent 2009-011417-24 DRKS00000657
WTZ-GIST-09-01 (Imatinib + LBH589) Informed Consent 2009-011417-24
Similar models
WTZ-GIST-09-01 (Imatinib + LBH589) Informed Consent 2009-011417-24
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Date of informed consent
Item
Date of informed consent
date
C2985782 (UMLS CUI [1])
Inclusion Criteria
Item
All inclusion criteria confirmed
boolean
C1512693 (UMLS CUI [1])
Exclusion Criteria
Item
At least one exclusion criterion present?
boolean
C0680251 (UMLS CUI [1])